Correlation Between Xbrane Biopharma and BioArctic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xbrane Biopharma and BioArctic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xbrane Biopharma and BioArctic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xbrane Biopharma AB and BioArctic AB, you can compare the effects of market volatilities on Xbrane Biopharma and BioArctic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xbrane Biopharma with a short position of BioArctic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xbrane Biopharma and BioArctic.

Diversification Opportunities for Xbrane Biopharma and BioArctic

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Xbrane and BioArctic is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Xbrane Biopharma AB and BioArctic AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioArctic AB and Xbrane Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xbrane Biopharma AB are associated (or correlated) with BioArctic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioArctic AB has no effect on the direction of Xbrane Biopharma i.e., Xbrane Biopharma and BioArctic go up and down completely randomly.

Pair Corralation between Xbrane Biopharma and BioArctic

Assuming the 90 days trading horizon Xbrane Biopharma AB is expected to generate 1.81 times more return on investment than BioArctic. However, Xbrane Biopharma is 1.81 times more volatile than BioArctic AB. It trades about 0.02 of its potential returns per unit of risk. BioArctic AB is currently generating about -0.09 per unit of risk. If you would invest  16.00  in Xbrane Biopharma AB on October 25, 2024 and sell it today you would earn a total of  0.00  from holding Xbrane Biopharma AB or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy94.12%
ValuesDaily Returns

Xbrane Biopharma AB  vs.  BioArctic AB

 Performance 
       Timeline  
Xbrane Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xbrane Biopharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
BioArctic AB 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioArctic AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, BioArctic sustained solid returns over the last few months and may actually be approaching a breakup point.

Xbrane Biopharma and BioArctic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xbrane Biopharma and BioArctic

The main advantage of trading using opposite Xbrane Biopharma and BioArctic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xbrane Biopharma position performs unexpectedly, BioArctic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioArctic will offset losses from the drop in BioArctic's long position.
The idea behind Xbrane Biopharma AB and BioArctic AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments